Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000813342 | SCV000953700 | pathogenic | Chuvash polycythemia; Von Hippel-Lindau syndrome | 2019-06-24 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon 1 of the VHL gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 1 of the VHL gene. This is expected to result in an absent or disrupted protein product. Loss-of-function variants including gross deletions in VHL are known to be pathogenic. Deletions of exon 1 have been reported in the literature in several families and individuals affected with von Hippel-Lindau syndrome (PMID: 10830910, 8069305, 19764026). For these reasons, this variant has been classified as Pathogenic. |